Live Breaking News & Updates on Bob gerberich

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Additional Investment in Magnolia Medical

Investegate announcements from RTW Venture Fund Ltd, Additional Investment in Magnolia Medical

London , City-of , United-kingdom , Alexandra-taracanova , Charles-ryland , Julia-enright , Henry-wilson , Marc-andre-marcotte , Stephanie-sirota , George-beale , Ovid-amadi , Bob-gerberich

Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development

/PRNewswire/ Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture.

Joseph-bishop , Bob-gerberich , Greg-bullington , Magnolia-medical-technologies-inc , Regulatory-affairs , Leadership-team-at-suneva-medical-corporation , Product-development , Cardiovascular-dynamics-inc , Terumo-medical-corporation , Development-for-endologix-inc , Onset-medical-corporation

Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development

/PRNewswire/ Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture.

Joseph-bishop , Bob-gerberich , Greg-bullington , Magnolia-medical-technologies-inc , Regulatory-affairs , Leadership-team-at-suneva-medical-corporation , Product-development , Cardiovascular-dynamics-inc , Terumo-medical-corporation , Development-for-endologix-inc , Onset-medical-corporation

Magnolia Medical Awarded National GPO and Value-Based Contract from Premier Inc. for Steripath® Initial Specimen Diversion Device®

/PRNewswire/ Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture.

Bob-gerberich , Prnewswire-magnolia-medical-technologies-inc , Medical-technologies , Premier-inc , Micro-initial-specimen-diversion-device , Clinical-performance , Value-based-tier , Now-steripath , Magnolia-medical , Clinical-performance-guarantee , Initial-specimen-diversion-technique

Magnolia Medical Awarded National GPO and Value-Based Contract from Premier Inc. for Steripath® Initial Specimen Diversion Device®

/PRNewswire/ Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture.

Bob-gerberich , Prnewswire-magnolia-medical-technologies-inc , Medical-technologies , Premier-inc , Micro-initial-specimen-diversion-device , Clinical-performance , Value-based-tier , Now-steripath , Magnolia-medical , Clinical-performance-guarantee , Initial-specimen-diversion-technique